Thanks to Cedars-Sinai and interventional cardiologist Evan Zahn, MD, Cheryl Davis, 48, became the first person in the world to receive a new, implantable device for repairing congenital cardiac defects—without open-heart surgery.
Dr. Jon Sin exemplifies the role postdoctoral scientists play in Cedars-Sinai’s research efforts. Photo: Al Cuizon Cedars-Sinai is considered a leader in biomedical science for at least 144 reasons — which is the exact number of postdoctoral scientists who work Read On
In a landmark discovery, Cedars-Sinai investigators showed that more than 50 percent of sudden cardiac arrest patients experience warning symptoms up to a month before suffering the event — a deadly condition that, until now, seemed to strike without warning.
A study at Cedars-Sinai applies its individualized tactics to investigate how adverse pregnancy outcomes can be used to identify women at risk for cardiovascular disease.
A tiny molecule discovered by Cedars-Sinai Heart Institute investigators — and fittingly named the “banana protein” — might hold the key to predicting heart failure.
A heart transplant can save patients like Jim Stavis from near-death and return them to a normal life. The next challenge: making a new heart last a lifetime.
With the latest high-tech noninvasive cardiac imaging, seeing is actually believing for cardiac patients. Read On